{"id":395939,"date":"2020-12-08T17:29:08","date_gmt":"2020-12-08T22:29:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=395939"},"modified":"2020-12-08T17:29:08","modified_gmt":"2020-12-08T22:29:08","slug":"investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","title":{"rendered":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"},"content":{"rendered":"

<\/p>\n

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Minerva Neurosciences, Inc. (\u201cMinerva\u201d or \u201cthe Company\u201d) (NASDAQ: NERV<\/a>) for violations of the securities laws.\n<\/p>\n

\nThe investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Minerva announced on December 1, 2020, the results of its meeting with the FDA regarding its plan to New Drug Application (NDA) for roluperidone, to treat negative symptoms in schizophrenia. The FDA told the Company that an NDA submission for its drug \u201cwould be highly unlikely to be filed\u201d because of \u201csubstantial review issues due to the lack of two adequate and well-controlled trials to support efficacy claims.\u201d Previously, the Company announced on May 29, 2020, that its Phase III study failed to show statistically significant differences from placebo on both the primary and key secondary endpoints. When the market learned the truth about Minerva, investors suffered damages.\n<\/p>\n

\nIf you are a shareholder who suffered a loss, click here to participate<\/a>.\n<\/p>\n

\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com<\/a>, or by email at brian@schallfirm.com<\/a>.\n<\/p>\n

\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.\n<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201208006152\/en\/<\/a><\/span><\/p>\n

\nThe Schall Law Firm
\n
Brian Schall, Esq.
\n
310-301-3335
\n
info@schallfirm.com
\n<\/a>
www.schallfirm.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Minerva Neurosciences, Inc. (\u201cMinerva\u201d or \u201cthe Company\u201d) (NASDAQ: NERV) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Minerva announced on December 1, 2020, the results of its meeting with the FDA regarding its plan to New Drug Application (NDA) for roluperidone, to treat negative symptoms in schizophrenia. The FDA told the Company that … <\/p>\n

Continue reading “INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-395939","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Minerva Neurosciences, Inc. (\u201cMinerva\u201d or \u201cthe Company\u201d) (NASDAQ: NERV) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Minerva announced on December 1, 2020, the results of its meeting with the FDA regarding its plan to New Drug Application (NDA) for roluperidone, to treat negative symptoms in schizophrenia. The FDA told the Company that … Continue reading "INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T22:29:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\",\"datePublished\":\"2020-12-08T22:29:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"},\"wordCount\":359,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\",\"name\":\"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-08T22:29:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","og_description":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Minerva Neurosciences, Inc. (\u201cMinerva\u201d or \u201cthe Company\u201d) (NASDAQ: NERV) for violations of the securities laws. The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Minerva announced on December 1, 2020, the results of its meeting with the FDA regarding its plan to New Drug Application (NDA) for roluperidone, to treat negative symptoms in schizophrenia. The FDA told the Company that … Continue reading \"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-08T22:29:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm","datePublished":"2020-12-08T22:29:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"},"wordCount":359,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/","name":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-08T22:29:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208006152r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-of-100000-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Minerva Neurosciences, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=395939"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395939\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=395939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=395939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=395939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}